Hartley Medical Recalls Prolotherapy with Phenol Used for Neurolysis

Hartley Medical is voluntarily recalling three lots of Prolotherapy with Phenol, Injectable to the hospital/user level due to non-sterility concerns.

Parenteral administration of non-sterile injection products that are intended to be sterile may result in a site-specific or systemic infection, which in turn may cause hospitalization, significant morbidity (permanent organ damage), or a fatal outcome.

Hartley Medical
The national leader in intra-spinal therapy, Hartley Medical specializes in the compounding of quality sterile pharmaceuticals for infusion therapy clients throughout the United States.

To date Hartley Medical has not received any reports of product contamination and/or adverse events related to this recall. This recall is a voluntary measure taken following a recent inspection with issues on our sterility methods and testing procedures specifically for this preparation.

Prolotherapy with Phenol is used for neurolysis and is packaged in clear 5 mL and/or 100 mL sterile vials with labeling of the pharmacy and the drug.

The affected Prolotherapy with Phenol lots include the following lot numbers and expiration dates:

RX328690Expires 12/1/2015
RX323132Expires 10/6/2015
RX321608Expires 11/1/2015

The product can be identified by its white label on each vial with the name “PROLOTHERAPY WITH PHENOL”. Product was distributed in California and Nevada to pain clinics between 5/15/15 – 7/14/15.

Hartley Medical is notifying its distributors and customers by telephone, facsimile, electronic mail and/or regular mail and is arranging a return of all recalled products.

Consumers/distributors/retailers that have Prolotherapy with Phenol which is being recalled should stop using the product and return its remaining contents to the pharmacy.

To return product or request assistance related to this recall, users should call (562) 595-7548, Monday through Friday, from 9:00 a.m. to 5:30 p.m. PDT. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program online: www.fda.gov/medwatch/report.htm1

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Source: FDA
Consumer Contact: (562) 595-7548
Recall Date: August 17, 2015

Comment on this Story